Articles tagged with Neuropathology
A new study reveals how defective dopamine packaging in neurons triggers toxic processes, leading to Parkinson's disease symptoms. Researchers discovered that delivering energy via ATP can repair packaging and halt damage.
Researchers at Amsterdam UMC found that a second pregnancy changes the female brain in unique ways, altering brain networks involved in attention and sensory cues. The study also linked structural brain changes to maternal mental health, providing new insights into postpartum depression.
A study by University of Virginia Health System researchers found that Medicare Advantage patients had better access to preventive care and rehabilitation after a stroke, leading to faster recovery times. In contrast, traditional Medicare patients were less likely to receive these services due to prior authorization requirements.
Professor Adelheid Wöhrer discussed innovative diagnostic platforms and collaborative research strategies for better understanding treatment-resistant glioblastoma. Her team is developing a novel diagnostic platform combining Virtual Raman Histology and real-time Nanopore Sequencing to enhance surgical accuracy.
New research reveals that the immune system has a potent weapon against the brain parasite Toxoplasma gondii: an enzyme called caspase-8. This discovery offers new insights into how our bodies control the parasite and may lead to better treatments for patients with compromised immune systems.
Researchers at the University of Illinois discovered that propofol, a common anesthetic agent, can improve cognitive function after surgery in older individuals. Additionally, intranasal insulin was found to mitigate age-related memory impairment by modulating neuroinflammatory mechanisms.
Researchers developed a new tool, Fear Avoidance after Concussion Tool (FACT), to assess fear avoidance behavior following a concussion. The 28-item questionnaire can be completed in five minutes, enabling targeted management for individuals at risk of persisting post-concussion symptoms.
A recent UK study has highlighted the need for equitable investment and adoption of new innovations in brain tumor care. The research team found that genomic testing has expanded rapidly but many services are struggling to keep pace, leading to regional inequalities in access to advanced treatments.
Researchers at UVA School of Medicine found that the breakdown of protective brain structures called perineuronal nets leads to social memory loss in Alzheimer's patients. Preventing the degradation of these nets may lead to new treatments to prevent or delay the disease.
African nations are well-equipped to tackle dementia and brain health with the Africa Task Force on Brain Health. The six-year framework will accelerate preparedness and protect aging citizens.
Scientists found a promising candidate, pleiotrophin, which is essential for brain development and function; restoring it may improve brain circuits in individuals with Down syndrome and other neurological diseases. The study's findings suggest using modified viruses to deliver the protein directly into cells could lead to new treatments.
Researchers at La Jolla Institute for Immunology discovered that ALS is likely caused by an autoimmune reaction triggered by inflammatory CD4+ T cells targeting specific proteins in the nervous system. Anti-inflammatory CD4+ T cells may slow disease progression and prolong survival times.
A study by Columbia University researchers found that soccer heading causes damage to the brain's cerebral cortex, leading to cognitive deficits. The study used a new imaging technique to identify areas most damaged by repeated impacts from heading a soccer ball.
A University of Houston researcher found that recording brain activity while listening to a story can help diagnose primary progressive aphasia, a rare neurodegenerative syndrome. The method was up to 75% effective in classifying the disorder's subtypes using machine-learning algorithms and electroencephalography data.
Researchers discovered elevated TSPO levels in the brain of genetically engineered mouse models and human patients with familial Alzheimer's disease, indicating a potential biomarker for early detection. The study aims to explore how blocking or enhancing TSPO could halt disease progression.
A study found that fine particulate matter air pollution exposure is associated with increased dementia severity and Alzheimer disease neuropathologic changes. Population-based studies are needed to better understand this relationship.
A new study published in Sleep Medicine found that daily sleep patterns have a significant impact on cognitive function. Researchers discovered that individuals with moderate-to-regular sleep patterns performed better in cognitive assessments than those with highly irregular or rigid sleep patterns.
A study found that semaglutide and liraglutide use are associated with a higher risk of nonarteritic anterior ischemic optic neuropathy in older patients with type 2 diabetes. The GLP-1 receptor agonists showed varying levels of risk, with liraglutide posing the greatest threat.
Research reveals a direct connection between diabetic peripheral neuropathy and skeletal health, linking nerve damage to reduced cell signaling. The study shows that diabetic mice with nerve damage had weakened bones due to impaired nerve-bone communication.
Scientists have discovered that microglia play a crucial role in regulating blood flow to the brain, and targeting them may improve blood flow deficits. The study suggests that restoring microglia function could prevent or reverse memory-stealing diseases caused by lack of adequate blood flow.
A study of 34 children found significant differences in basal ganglia volume between those exposed to prenatal Superstorm Sandy and those not exposed. The findings suggest that extreme heat may have amplified the risk of having a differently-sized basal ganglia.
Researchers at University of Virginia Health System discovered that an immune molecule called STING drives the formation of harmful plaques and protein tangles associated with Alzheimer's. Blocking STING protected lab mice from mental decline, suggesting a promising treatment target for neurodegenerative diseases.
A new technique using focused sound waves and microbubbles has shown great promise in treating debilitating brain lesions called cerebral cavernous malformations. The approach has halted the growth of lesions almost entirely, offering a potential paradigm shift in treatment.
Richard Finkel, MD, is named to TIME100 Health for his pioneering work in treating spinal muscular atrophy prenatally with the orally administered drug risdiplam. This breakthrough has shown promising results, with no identifiable features of SMA observed two years after treatment.
A study published in JAMA Neurology found no evidence supporting a diagnosis of the New Brunswick neurological syndrome of unknown cause, highlighting the need for independent clinical evaluations. The data revealed presence of several neurodegenerative and non-neurodegenerative conditions instead
Researchers at KAIST have identified a key mechanism behind neuroinflammatory responses in Parkinson's disease, which is regulated by an RNA editing enzyme called ADAR1. This discovery suggests that targeting this enzyme could serve as a novel therapeutic strategy for treating the disease.
Researchers develop specialized enzymes to selectively increase or decrease specific mutation loads in mitochondria, allowing precise study of disease manifestation. This technology holds promise for treating patients with mitochondrial diseases by reducing mutant mtDNA load.
A cohort study found semaglutide use is associated with a higher risk of nonarteritic anterior ischemic optic neuropathy in people with diabetes. However, the retrospective design limits the study's ability to establish causality, necessitating further research.
A unique case study reveals an unexpected discrepancy between Alzheimer's pathology and cognitive function in a woman with Down syndrome. The study highlights the need to expand inclusion criteria for therapeutic drug trials and uncover genetic or lifestyle factors that contribute to cognitive preservation.
A study at Lund University found that brain trauma triggers Alzheimer's disease through vascular changes, challenging existing paradigms. The research team identified increased aggregation of amyloid-beta and vascular alterations in patients with traumatic brain injury.
Researchers linked genes to hallmark features like tau tangles and amyloid plaques, as well as other less understood brain changes. The study identified a genetic variant in the APH1B gene directly influencing tau tangle formation, and confirmed the APOE gene's role in granulovacuolar degeneration.
Researchers found that individuals with depression who engage in reflexive emotion regulation experience increased suicidal thoughts during daily stressful events. In contrast, adaptive responses to stress were observed when participants used reappraisal strategy.
A third of living former professional football players reported perceived chronic traumatic encephalopathy (CTE) associated with an increased prevalence of suicidality. Men with CTE had cognitive impairment and more health problems compared to those without CTE, highlighting a novel risk factor for suicidality.
Researchers have developed a new diagnostic algorithm using positron emission tomography (PET) to distinguish between Alzheimer's disease and primary tauopathy. The biomarkers enable doctors to identify the presence of a 4-repeat tauopathy with high accuracy, facilitating earlier diagnosis and personalized treatment strategies.
Researchers studied Alzheimer disease blood biomarkers and found a strong association with incident all-cause dementia risk. Biomarker levels increased with age and were linked to dementia starting in midlife.
Researchers from Tokyo Medical and Dental University demonstrate a proof of concept for antisense nucleic acid therapy to prevent the spread of α-synuclein pathologies in synucleinopathies. The treatment, involving antisense oligonucleotides, effectively reduces Lewy pathology-like neuronal inclusion by over 90%.
A recent study found that oleacein increases BDNF expression in human neuronal cells and reduces depressive behavior in mouse models. Gene expression analysis reveals the activation of cell cycle and neurogenesis processes, as well as a decrease in inflammatory response.
Research at the University of Zurich reveals that the first week after birth is a critical period for the development of senses, particularly smell and touch. Olfactory stimuli can induce neural activity across multiple brain regions, including areas responsible for non-olfactory sensory processing.
Researchers have discovered two independent ways genetic variants in HTRA1 increase cardiovascular disease risk, including stroke. The study found that rare and common variants affect protease activity and concentration, respectively.
Researchers created a corticolimbic index tool that categorizes Alzheimer's disease into three subtypes based on brain changes. The study found demographic and clinical differences among sex, age at onset, and rate of cognitive decline.
Researchers from Osaka University found that influenza-associated brain disorders may be caused by the virus entering the brain and producing proteins. Antivirals blocking protein production are unlikely to be effective, but those targeting transcription and translation may offer hope for treatment.
A healthy lifestyle can help maintain cognitive abilities in older adults with common neuropathologies of dementia. The study found that a balanced lifestyle provides cognitive reserve, protecting against cognitive decline.
Researchers found that baseline amyloid burden and brain health are stronger predictors of Alzheimer's progression than age alone. The study also showed that individuals with higher amyloid levels developed dementia two years earlier than those without.
A review in the Journal of Neurochemistry suggests a link between COVID-19 and Alzheimer's disease, with age being the largest contributing factor. Emerging evidence may further support this association, with research assessing influences on AD neuropathology.
A new study published in JAMA Neurology found that over 40% of young contact and collision sport athletes have CTE, a degenerative brain disease caused by repetitive head impacts. The study also highlighted the importance of assessing symptoms and clinical presentation of CTE in living athletes.
Researchers from Tokyo Medical and Dental University discovered a new mechanism that stimulates brain-autonomous neural repair after ischemic stroke by secreting lipids. The mechanism involves PLA2G2E, which increases dihomo-γ-linolenic acid (DGLA) levels, promoting inflammation reduction and neuronal repair.
A secondary analysis of a randomized clinical trial found that exercise can significantly reduce symptoms of chemotherapy-induced peripheral neuropathy (CIPN) in ovarian cancer survivors. Incorporating exercise programs into standard oncology care may improve quality of life for these patients.
A study published in Stroke identified two proteins, R-spondin 3 (RSPO3) and LGR4, that trigger a signaling pathway to reduce inflammation and promote neurite outgrowth in the ischemic brain. This discovery provides new hope for patients with ischemic stroke by targeting RSPO3/LGR4 signaling.
Researchers at UC Davis discovered how oligodendrocyte-lineage cells transfer cell material to neurons in the mouse brain, providing a new mechanism for understanding brain maturation and finding treatments for neurological conditions. This discovery opens new possibilities for treating neurodegenerative diseases like Alzheimer's and P...
Taiyun Chi develops a neural interface with neural recording channel counts over 10 times higher than current technology and creates a noninvasive deep-brain-stimulation system based on temporally interfering electromagnetic waves.
Researchers found that platelet depletion increased amyloid plaque size and neuronal damage in APP-PS1 mice. However, platelets may have a beneficial role in limiting plaque growth and attenuating neuritic dystrophy at advanced stages of Alzheimer's disease.
A recent review strengthens the connection between repetitive head impacts and chronic traumatic encephalopathy (CTE), highlighting a strong dose response relationship. CTE has been diagnosed in over 600 cases, with 97% of confirmed cases showing exposure to RHI, primarily through contact sports.
A new study published in Anaesthesia has found no statistically significant differences in neurodevelopmental outcomes between children exposed to anaesthesia during pregnancy and those not exposed. The study, led by Professor Steffen Rex, comprehensively evaluated over 500 children aged 2-18 years using standardized tools.
Researchers found lower serum TDP-43 levels in patients with C9orf72 repeat expansion or motoneuron disease, distinguishing them from other FTD subtypes. This study suggests TDP-43 as a potential biomarker for diagnosing specific FTD subtypes, enabling patient-specific interventions.
The study used a weakly supervised deep learning algorithm to analyze human brain autopsy tissues and predict the presence or absence of cognitive impairment. The model identified a signal associated with decreasing myelin staining, which was linked to cognitive impairment in the white matter.
A multi-institutional team assessed the diagnostic criteria for canine glioma using the Comparative Brain Tumor Consortium's guidelines. The study found that consensus was achieved for 71 out of 85 cases (84%), with a moderate level of inter-pathologist agreement.
A new study introduces a novel epigenetic predictor, PCBrainAge, that captures aging heterogeneity across multiple brain regions. The tool demonstrates stronger associations with AD dementia and pathologic AD compared to existing age predictors.
Researchers at City University of Hong Kong discovered a new neural mechanism that enables animals to perceive and integrate environmental cues, such as air puffs and sounds, to initiate defensive behavior. This finding has implications for understanding schizophrenia patients' auditory hallucinations.
Researchers found that biomarkers of Alzheimer's disease pathology, such as amyloid-beta and tau proteins, were associated with increased anxiety and apathy in cognitively unimpaired older adults. Higher levels of apathy were also linked to a more rapid cognitive decline.
Researchers discovered that inhibiting the breakdown of a neuroprotective molecule called 2-arachidonoylglycerol (2-AG) in astrocytes promotes recovery from traumatic brain injury. The study suggests that targeting this molecule could lead to the development of new therapies for TBI-induced disease.